Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 21, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for April 28, 2008 Subscribe to this News Feed      
 

VitalCare Signs LOI For Diabetes Treatment Center In Utah

Center Will Provide iCAT Therapy for Type 1 and Type 2 Diabetics

CARSON CITY, Nev. (Business Wire EON/PRWEB ) April 28, 2008 -- VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets:VDTI) a Nevada corporation, today announced they have signed a letter of intent to establish a joint-venture relationship with South Valley Inpulse Center, LLC, an existing Diabetes Treatment Center in Draper, Utah. The center will be administering the FDA approved iCAT treatment for Type 1 and Type 2 diabetes patients.

We are excited about this opportunity to work with VitalCare to expand our program, giving more people access to this treatment and the hope in a better quality of life.
Jimmy McDougald, CEO, stated, This is the part of our Mid-West launch and we are excited to be offering iCAT therapy to diabetics in this region. We see this as an opportunity to work with an established team of healthcare professionals.

News Image Diana Harrison, Managing Partner of South Valley Inpulse Center, said, We are excited about this opportunity to work with VitalCare to expand our program, giving more people access to this treatment and the hope in a better quality of life.

About VitalCare Diabetes Treatment Centers, Inc.

VitalCare Diabetes Treatment Centers, Inc. is a company specializing in providing Administrative, Marketing, Business Development, Strategic Planning, Clinical Oversight and Clinical Management Services to the Diabetes Healthcare Sector, with an emphasis in bringing Cutting Edge medical devices and healthcare services direct to consumers, focusing on an emerging FDA approved, US and European Patented technology and treatment intervention for treating Type 1 and Type 2 Diabetes known as Intracellular Activation Therapy (iCAT).

Safe Harbor Statement: Forward-looking statements in this release with respect to VitalCare Diabetes Treatment Centers, Inc.s business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward- looking statements, including, but not limited to, certain delays beyond VitalCare Diabetes Treatment Centers, Inc.s control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in VitalCares filings with the Securities and Exchange Commission.

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1Db3VwLUNvdXAtSG9yci1GYWx1LVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION

VitalCare Diabetes Treatment Centers, Inc.
Investor Relations:
Jimmy McDougald, 1-909-981-9192
Fax: 1-909-931-1780
Toll Free: 1-877-NO-DIABETES
info@vitalcaretechnology.com

ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files by creating a Smart News Release at Business Wire.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright